series-b
Stage
2018
Founded
1
Investors
About
SonoThera develops a proprietary, nonviral, ultrasound-mediated gene delivery platform to treat the root cause of genetic diseases by enabling broad, targeted biodistribution of genetic payloads without size restriction.
Explore SonoThera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.